Crossmark

Standardized HILIC-FLD N-Glycan Analysis for Assessing N-Glycosylation Heterogeneity and Glycosylation-Related Quality Attributes in Bevacizumab from Multiple Manufacturers

Crossref DOI link: https://doi.org/10.1007/s10337-025-04407-6

Published Online: 2025-04-11

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lou, Doudou

Zhu, Yuan

Fan, Jingke

Fan, Lin

Zhu, Qingfu

Lu, Yihong

Zhao, Shuqiang
Funding

Funding for this research was provided by:

the Scientific Research Plan for Drug Regulation, Jiangsu Provincial Medical Products Administration (202208)
License Information

Text and Data Mining valid from 2025-04-11

Version of Record valid from 2025-04-11
More Information

Article History

Received: 10 January 2025

Revised: 21 March 2025

Accepted: 22 March 2025

First Online: 11 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below